Foster

Medicinal product

(Invented) name

Foster

Active substance (s)

Beklometazono dipropionatas/Formoterolio fumaratas dihidratas

Strength

200 µg/12 µg/dozėje

Pharmaceutical form

įkvepiamieji milteliai

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03AK08, Formoterol and beclometasone

Marketing authorisation holder

Chiesi Pharmaceuticals GmbH, Austrija

Date of authorisation

2020-04-29

Date of renewal

Documents

4546_1_3 Foster 200_12 ikv milt PCS 200429, PL 201023.docx

4546_1_3 Pakuotės lapelis 201023.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10b

Procedure number

DE/H/0873/006/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Kiekvienoje išmatuotoje dozėje yra:	1 dozėje
Beklometazono dipropionatas	200 µg
Formoterolio fumaratas dihidratas	12 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
103954	90056	1090056	inhaliatorius	60 dozių N1		Receptinis	LT/1/20/4546/001	Netiekiama	-	-	No	-	-
103955	90057	1090057	inhaliatorius	60 dozių N2		Receptinis	LT/1/20/4546/002	Netiekiama	-	-	No	-	-
103956	90058	1090058	inhaliatorius	60 dozių N3		Receptinis	LT/1/20/4546/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-07-31	Išregistruotas
2020-04-29	Registruotas